215 related articles for article (PubMed ID: 19143876)
1. Erythropoietin therapy in cancer-related anaemia, yes or no?
Herrmann R
Intern Med J; 2008 Oct; 38(10):749-50. PubMed ID: 19143876
[No Abstract] [Full Text] [Related]
2. [Use of erythropoietin in the treatment of cancer-related anemia].
Huang JX; Meng FJ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
[No Abstract] [Full Text] [Related]
3. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Anand A; Anand A; Anand N
Cancer; 1996 May; 77(9):1960-1. PubMed ID: 8646701
[No Abstract] [Full Text] [Related]
4. Is anemia of cancer different from chemotherapy-induced anemia?
Steensma DP
J Clin Oncol; 2008 Mar; 26(7):1022-4. PubMed ID: 18227523
[No Abstract] [Full Text] [Related]
5. Erythropoietin: high profile, high scrutiny.
Crawford J
J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
[No Abstract] [Full Text] [Related]
6. Erythropoietin-stimulating agents: new data yield new insights.
Zitella L
Oncology (Williston Park); 2007 Oct; 21(11 Suppl Nurse Ed):36-8. PubMed ID: 18154208
[No Abstract] [Full Text] [Related]
7. [Concern about the safety of erythropoietin in cancer patients].
van der Lelie J
Ned Tijdschr Geneeskd; 2008 Apr; 152(16):920-2. PubMed ID: 18561786
[TBL] [Abstract][Full Text] [Related]
8. Anemia: cancer patients who are very likely to benefit often go untreated.
J Support Oncol; 2003; 1(1):68. PubMed ID: 15352647
[No Abstract] [Full Text] [Related]
9. Advocating recombinant human erythropoietin as standard practice in Europe for treatment of cancer-related anaemia.
Coiffier B
Ann Oncol; 2003 May; 14(5):804. PubMed ID: 12702538
[No Abstract] [Full Text] [Related]
10. Therapeutic use of erythropoietin in dermatooncology.
Satzger I; Schenck F; Thol F; Ganser A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2007 Apr; 5(4):280-5. PubMed ID: 17376091
[TBL] [Abstract][Full Text] [Related]
11. [Severe fatigue in cancer. Causes from A as anemia to Z as cytostatics].
MMW Fortschr Med; 2004 Mar; 146(11):57. PubMed ID: 15152776
[No Abstract] [Full Text] [Related]
12. Erythropoietin usage in patients with cancer.
Wood PA; Hrushesky WJ
Cancer J Sci Am; 1995; 1(4):243-6. PubMed ID: 9166482
[No Abstract] [Full Text] [Related]
13. Implementation and application of anemia clinical practice guidelines.
Winn RJ; Muller RJ; Cella D
J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-33-9. PubMed ID: 23573552
[No Abstract] [Full Text] [Related]
14. The clinical utility of epoetin in cancer patients: a matter of perspective.
Barosi G; Marchetti M
Haematologica; 2000 May; 85(5):449-50. PubMed ID: 10800156
[No Abstract] [Full Text] [Related]
15. Prediction of chemotherapy-induced anaemia: is knowledge really power?
Spivak JL
Lancet Oncol; 2005 Nov; 6(11):822-4. PubMed ID: 16257787
[No Abstract] [Full Text] [Related]
16. Clarifying the use of erythropoietic agents.
Smith RE
J Support Oncol; 2004; 2(3):200, 202; author reply 202. PubMed ID: 15328822
[No Abstract] [Full Text] [Related]
17. Erythropoietin: can we afford to use it? Can we afford not to?
Laird J
Transfus Med; 2006 Jun; 16(3):204-5. PubMed ID: 16764600
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin for anaemia in Chinese cancer patients on chemotherapy.
Chan AT; Leung WT; Lin J; Yeo W; Johnson PJ
Clin Oncol (R Coll Radiol); 1995; 7(4):272. PubMed ID: 8845332
[No Abstract] [Full Text] [Related]
19. Management options for cancer therapy-related anaemia.
Littlewood TJ
Drug Saf; 2002; 25(7):525-35. PubMed ID: 12093310
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced anemia.
Miller CB
Contrib Nephrol; 1991; 88():248-51; discussion 252-3. PubMed ID: 2040186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
